Condition: Asthma
Interventions: Drug: MSTT1041A; Drug: Placebo
Sponsor: Hoffmann-La Roche
Recruiting – verified September 2016
View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
Feasibility of a Clinician Training Program to Improve Patient-provider Communication in the Presence of Health IT Systems in the Exam Room
Condition: Asthma
Intervention: Behavioral: EHR-Physician Asthma Care Education Program
Sponsors: University of Michigan; Agency for Healthcare Research and Quality (AHRQ)
Recruiting – verified September 2016
View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
Electronic Monitoring of Medication Adherence in Moderate to Severe Asthma Patients
Condition: Asthma
Intervention: Behavioral: Electronic sensor and OW education
Sponsor: Montefiore Medical Center
Not yet recruiting – verified September 2016
View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
Early Risk of Asthma in Children Exposed to In-utero Maternal Obesity
Conditions: Asthma; Children; Obesity; Maternal
Intervention:
Sponsor: Pontificia Universidad Catolica de Chile
Enrolling by invitation – verified September 2016
View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
An Open-label Study to Evaluate the Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma
Condition: Inadequately Controlled Asthma
Intervention: Biological: Tralokinumab open-label
Sponsor: AstraZeneca
Not yet recruiting – verified September 2016
View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
Controlled Clinical Study of Dupilumab in Patients With Nasal Polyps
Condition: Nasal Polyps
Interventions: Drug: Dupilumab SAR231893 (REGN668); Drug: Placebo; Drug: Mometasone furoate nasal spray
Sponsors: Sanofi; Regeneron Pharmaceuticals
Not yet recruiting – verified August 2016
View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
Effects of a Orally Inhaled Fluticasone Furoate on Growth Velocity in Prepubertal, Paediatric Subjects With Asthma Over a Year
Condition: Asthma
Interventions: Drug: Fluticasone furoate; Drug: Placebo; Drug: Montelukast; Drug: Short Acting Beta 2 Agonist
Sponsor: GlaxoSmithKline
Not yet recruiting – verified August 2016
View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
Efficacy and Safety of Indacaterol Acetate Delivered Via the Concept1 Inhalation Device in Children Greater or Equal to 6 and Less Than 12 Years of Age With Asthma
Condition: Asthma
Interventions: Drug: Indacaterol acetate 75 ?g; Drug: Indacaterol acetate 150 ?g
Sponsor: Novartis Pharmaceuticals
Not yet recruiting – verified August 2016
View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
Non-interventional Study of COPD Patients With Asthma Overlap Syndrome in Viet Nam and Taiwan.
Condition: Patients With Asthma-COPD Overlap Syndrome (ACOS)
Intervention:
Sponsors: AstraZeneca; ASK CRE Private Limited
Not yet recruiting – verified August 2016
View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
Characterization of Adults for Asthma Microbiome Research Studies
Conditions: Asthma; Healthy
Intervention:
Sponsors: University of Michigan; National Institutes of Health (NIH)
Recruiting – verified August 2016
View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days